HCMT
HZNP

Highland Capital Management (Tennessee)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,211
Closed -$1.75M – 364
2022
Q3 		$1.75M Sell
28,211
-241
-0.8% -$16.8K 0.13% 162
2022
Q2 		$2.27M Hold
28,452
– – 0.16% 155
2022
Q1 		$2.99M Sell
28,452
-409
-1% -$39.9K 0.18% 149
2021
Q4 		$3.11M Sell
28,861
-676
-2% -$73.7K 0.18% 142
2021
Q3 		$3.23M Sell
29,537
-2,586
-8% -$268K 0.2% 139
2021
Q2 		$3.01M Sell
32,123
-1,747
-5% -$161K 0.18% 143
2021
Q1 		$3.12M Sell
33,870
-1,333
-4% -$112K 0.19% 137
2020
Q4 		$2.58M Sell
35,203
-2,176
-6% -$162K 0.17% 153
2020
Q3 		$2.9M Buy
37,379
+1,132
+3% +$77.9K 0.21% 128
2020
Q2 		$2.02M Sell
36,247
-3,568
-9% -$153K 0.16% 145
2020
Q1 		$1.18M Sell
39,815
-3,165
-7% -$107K 0.11% 176
2019
Q4 		$1.56M Buy
+42,980
New +$1.32M 0.11% 188
2015
Q4 		– Sell
-5,000
Closed -$99K – 616
2015
Q3 		$99K Buy
5,000
+3,000
+150% +$94.8K 0.01% 328
2015
Q2 		$69K Buy
+2,000
New +$61K 0.01% 357

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Highland Capital Management (Tennessee)'s HZNP Position: Q4 2022 in Review

Highland Capital Management (Tennessee) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 28,211 shares — an estimated $1.75M sold.

Highland Capital Management (Tennessee) first reported a position in HZNP in Q2 2015 and held it in 14 quarters. The position peaked at $3.23M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Highland Capital Management (Tennessee) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 28,211 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.75M.
  • Highland Capital Management (Tennessee) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 14 quarters.
  • Highland Capital Management (Tennessee)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.23M in Q3 2021.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2022, filed 7 Feb 2023.